
Eiko Lifesciences Ltd is Rated Sell
2026-08-24 10:10:29Eiko Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 24 August 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
Read full news article
Eiko Lifesciences Ltd Falls to 52-Week Low of Rs 44.75 as Sell-Off Deepens
2026-08-17 10:20:36A sharp decline over the past two sessions has dragged Eiko Lifesciences Ltd to a fresh 52-week low of Rs 44.75 on 17 Aug 2026, marking a 7.04% intraday drop and extending its losing streak to five sessions. This downturn contrasts with the broader market, where the Sensex remains above its 50-day moving average despite a modest fall of 0.57% on the day.
Read full news article
Eiko Lifesciences Ltd Reports Positive Quarterly Growth Amid Market Challenges
2026-08-13 08:00:31Eiko Lifesciences Ltd, a micro-cap player in the Specialty Chemicals sector, reported a notably positive quarterly performance for June 2026, with robust revenue growth and record profitability metrics. Despite a downgrade in its Mojo Grade from Hold to Sell, the company’s latest financials reveal encouraging signs of operational strength, though challenges remain in its broader market performance and valuation.
Read full news article
Eiko Lifesciences Ltd is Rated Sell by MarketsMOJO
2026-08-12 10:10:03Eiko Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 August 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.
Read full news article
Eiko Lifesciences Ltd is Rated Sell by MarketsMOJO
2026-08-01 10:10:04Eiko Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 August 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Eiko Lifesciences Ltd is Rated Sell by MarketsMOJO
2026-08-01 10:10:04Eiko Lifesciences Ltd is rated Sell by MarketsMOJO, with this rating last updated on 15 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 August 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article
Eiko Lifesciences Ltd is Rated Sell
2026-07-21 10:10:04Eiko Lifesciences Ltd is rated Sell by MarketsMOJO, with this rating last updated on 15 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
Read full news article
Eiko Lifesciences Ltd is Rated Sell
2026-07-09 10:10:05Eiko Lifesciences Ltd is rated Sell by MarketsMOJO, with this rating last updated on 15 June 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock’s current position as of 09 July 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance.
Read full news article
Eiko Lifesciences Ltd is Rated Sell
2026-06-28 10:10:06Eiko Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 June 2026, providing investors with an up-to-date view of the company’s performance and outlook.
Read full news articleCompliance Under Regulation 36 Of The SEBI (Listing Obligations And Disclosures Requirements) Regulations 2015 (The Listing Regulations)
27-Aug-2026 | Source : BSEThe Company has sent a letter providing the weblink and QR Code for accessing the Notice convening the 49th Annual General Meeting ("AGM") and the Annual Report of the Company for the Financial Year 2025-26 to the following categories of shareholders:
Announcement under Regulation 30 (LODR)-Newspaper Publication
25-Aug-2026 | Source : BSENewspaper Advertisement for 49th Annual General Meeting (AGM) of the Company scheduled to be held on Tuesday 22nd day of September 2026 at 04:00 P.M. IST through Video Conference / Other Audio-Visual Means
Reg. 34 (1) Annual Report.
24-Aug-2026 | Source : BSEPursuant to provision of Regulations 30 and 34 of the SEBI LODR Regulations 2015 we wish to inform that the 49th Annual General Meeting of the Company will be held on Tuesday 22nd day of September 2026 at 04:00 P.M. (IST) through Video Conferencing/ Other Audio Visual Means.
Corporate Actions
No Upcoming Board Meetings
Eiko Lifesciences Ltd has declared 2% dividend, ex-date: 20 Sep 17
No Splits history available
No Bonus history available
Eiko Lifesciences Ltd has announced 2:3 rights issue, ex-date: 07 Jul 23






